CONCLUSIONS — The addition of orlistat to lifestyle intervention was associated with
maintenance of an extra 2.4 kg weight loss after VLED for up to 3 years in obese subjects. The
combination of orlistat and lifestyle intervention was associated with a reduced occurrence of
type 2 diabetes.